المؤلفون: James F. Donohue, Anthony D'Urzo, Kenneth R. Chapman, Dave Singh

المصدر: Therapeutic Advances in Respiratory Disease
Therapeutic Advances in Respiratory Disease, Vol 13 (2019)

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Adult, medicine.medical_specialty, Fixed-dose combination, formoterol, Review, Muscarinic Antagonists, Severity of Illness Index, 03 medical and health sciences, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Aclidinium bromide, Maintenance therapy, aclidinium, Internal medicine, Formoterol Fumarate, medicine, COPD, long-acting muscarinic antagonist, Humans, Pharmacology (medical), 030212 general & internal medicine, long-acting β2-agonist, Adrenergic beta-2 Receptor Agonists, lcsh:RC705-779, biology, maintenance treatment, business.industry, lcsh:Diseases of the respiratory system, Lama, medicine.disease, biology.organism_classification, Obstructive lung disease, 3. Good health, bronchodilators, Bronchodilator Agents, Drug Combinations, 030228 respiratory system, Quality of Life, Formoterol, business, medicine.drug, Tropanes

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a2e6e558b3eb232ce3210aff2bd5a26Test
http://europepmc.org/articles/PMC6535700Test

المؤلفون: Ho Cheol, Kim, Tae Hoon, Kim, Chin Kook, Rhee, Minkyu, Han, Yeon-Mok, Oh

المصدر: Therapeutics and Clinical Risk Management

مصطلحات موضوعية: tuberculosis, long-acting muscarinic antagonist, survival, propensity score, Original Research

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid________::76d6eb37a95be3229181fc6f14bd45a9Test
https://pubmed.ncbi.nlm.nih.gov/30881003Test

المؤلفون: Srikanth Pendyala, Borje Darpo, Chris N. Barnes, Hongqi Xue, David L. Bourdet, Marie T. Borin

المصدر: Clinical Pharmacology in Drug Development

مصطلحات موضوعية: Adult, Male, Adolescent, Pharmaceutical Science, Original Manuscript, Muscarinic Antagonists, Placebo, 030226 pharmacology & pharmacy, QT interval, 03 medical and health sciences, QRS complex, Electrocardiography, Young Adult, 0302 clinical medicine, Double-Blind Method, Moxifloxacin, Heart Rate, Heart rate, nebulized, medicine, Humans, COPD, Pharmacology (medical), Cross-Over Studies, Inhalation, business.industry, long‐acting muscarinic antagonist, Articles, Middle Aged, Crossover study, Confidence interval, Healthy Volunteers, Long QT Syndrome, revefenacin, 030220 oncology & carcinogenesis, Anesthesia, Benzamides, healthy subjects, Female, Carbamates, moxifloxacin, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3658f41dbb1e0e2f5d0a8b4dcfad8781Test
https://pubmed.ncbi.nlm.nih.gov/31468714Test

المؤلفون: Takafumi Yamaya, Tatsuya Ogimoto, Hwang Moon Hee, Ryoichi Ishikawa, Kenta Nishi, Chie Yoshimura, Erika Nakai, Naoki Yamada, Takayuki Aoyagi, Yasuo Nishizaka

المصدر: Respiratory Medicine Case Reports, Vol 28, Iss, Pp-(2019)
Respiratory Medicine Case Reports

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, medicine.medical_specialty, Case Report, Pembrolizumab, Lung biopsy, Gastroenterology, Inhaled corticosteroid, Internal medicine, Immune checkpoint inhibitors-related lung disease, Medicine, Lung cancer, Diffuse alveolar damage, lcsh:RC705-779, Lung, business.industry, lcsh:Diseases of the respiratory system, respiratory system, medicine.disease, Discontinuation, respiratory tract diseases, Long-acting muscarinic antagonist, medicine.anatomical_structure, Bronchiolitis, Long-acting β2 agonist, Adenocarcinoma, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7464e4a1cf03e06424e5d9c37e07102Test
http://www.sciencedirect.com/science/article/pii/S2213007119300395Test

المؤلفون: Ermanno Puxeddu, Maria Gabriella Matera, Paola Rogliani, Mario Cazzola

المساهمون: Cazzola, M., Puxeddu, E., Matera, M. G., Rogliani, P.

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, medicine.medical_specialty, Settore MED/10 - Malattie dell'Apparato Respiratorio, MEDLINE, long-acting β, Muscarinic Antagonists, Cochrane Library, Fixed dose, inhaled corticosteroid, long-acting muscarinic antagonists, Adrenal Cortex Hormones, Administration, Inhalation, Immunology and Allergy, Medicine, Asthmatic patient, Humans, long-acting muscarinic antagonist, In patient, Asthma, inhaled corticosteroids, long-acting β-agonists, single inhaler triple therapy, Intensive care medicine, Adrenergic beta-2 Receptor Agonists, biology, business.industry, Inhaler, Public Health, Environmental and Occupational Health, Lama, biology.organism_classification, medicine.disease, agonist, Drug Therapy, Combination, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9561545e186e9b13c0999f67c7e0d7bTest
http://hdl.handle.net/2108/222237Test

المؤلفون: Francesco Blasi, Claudio Micheletto, Paola Rogliani, Luigino Calzetta, Stefano Centanni, Fabiano Di Marco, Andrea Rossi, Mario Cazzola

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, medicine.medical_specialty, Exacerbation, Trough forced expiratory volume in 1 s, Settore MED/10 - Malattie dell'Apparato Respiratorio, Muscarinic Antagonists, Severity of Illness Index, Fluticasone propionate, 03 medical and health sciences, chemistry.chemical_compound, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Inhaled corticosteroid, Long-acting β(2) agonist, Internal medicine, medicine, Humans, Pharmacology (medical), 030212 general & internal medicine, Chronic obstructive pulmonary disease, Long-acting muscarinic antagonist, Network meta-analysis, Adrenergic beta-2 Receptor Agonists, Glucocorticoids, Randomized Controlled Trials as Topic, COPD, biology, business.industry, Biochemistry (medical), Lama, biology.organism_classification, medicine.disease, respiratory tract diseases, Bronchodilator Agents, Drug Combinations, 030228 respiratory system, chemistry, Indacaterol, Vilanterol, Formoterol, Salmeterol, business, hormones, hormone substitutes, and hormone antagonists, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4122f27c4acc579e6a1f3efba23c769Test
http://hdl.handle.net/2108/222245Test

المؤلفون: Luigino Calzetta, Paola Rogliani, Mario Cazzola, Maria Gabriella Matera

المساهمون: Calzetta, Luigino, Matera, Maria Gabriella, Cazzola, Mario, Rogliani, Paola

المصدر: Advances in Therapy

مصطلحات موضوعية: Male, Long-acting β2-agonist, Pharmacology, law.invention, chemistry.chemical_compound, Pulmonary Disease, Chronic Obstructive, Randomized controlled trial, law, Forced Expiratory Volume, Pulmonary Medicine, Settore MED/10, Pharmacology (medical), COPD, biology, Brief Report, Olodaterol, Human isolated airways, Fixed-dose combination, General Medicine, Lama, Middle Aged, humanities, Respiratory Function Tests, Bronchodilator Agents, Synergy, Drug Combinations, Treatment Outcome, Respiratory, Female, Drug Monitoring, Respiratory/pulmonary, medicine.drug, Chronic Obstructive, Combination therapy, Drug development, Muscarinic Antagonists, Pulmonary Disease, Double-Blind Method, medicine, Humans, LABA/LAMA combination, Tiotropium Bromide, Triple therapy, Adrenergic beta-2 Receptor Agonists, Asthma, Aged, Dose-Response Relationship, Drug, business.industry, Dose-finding, Muscarinic antagonist, medicine.disease, biology.organism_classification, Human isolated airway, respiratory tract diseases, Benzoxazines, Long-acting muscarinic antagonist, chemistry, Commentary, business, human activities

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29e8233fcbdbea458e82d3960e470a5eTest
http://hdl.handle.net/2108/262688Test

المؤلفون: Dave Singh, Stefano Petruzzelli, Piotr Kuna, Maxim Kots, Pierluigi Paggiaro, A. Vele, Alberto Papi, Florence Zuccaro, Sandrine Corre, Johann Christian Virchow, Giorgio Walter Canonica, George Georges

المصدر: Virchow, J C, Kuna, P, Paggiaro, P, Papi, A, Singh, D, Corre, S, Zuccaro, F, Vele, A, Kots, M, Georges, G, Petruzzelli, S & Canonica, G W 2019, ' Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials ', The Lancet, vol. 394, no. 10210, pp. 1737-1749 . https://doi.org/10.1016/S0140-6736Test(19)32215-9

مصطلحات موضوعية: Male, parallel-group, 030204 cardiovascular system & hematology, Gastroenterology, law.invention, Tertiary Care Centers, 0302 clinical medicine, Randomized controlled trial, exacerbations, law, Formoterol Fumarate, 030212 general & internal medicine, TRIGGER, Inhalation, Beclomethasone, General Medicine, Middle Aged, respiratory system, Drug Combinations, Treatment Outcome, triple therapy, Corticosteroid, Female, double-blind, randomised, medicine.drug, Adult, medicine.medical_specialty, long-acting β2 agonist, medicine.drug_class, Socio-culturale, TRIMARAN, controlled phase trials, inhaled corticosteroid, Drug Administration Schedule, Young Adult, 03 medical and health sciences, Double-Blind Method, Internal medicine, Administration, Inhalation, medicine, Humans, long-acting muscarinic antagonist, Adverse effect, Secondary Care Centers, Aged, Asthma, business.industry, Uncontrolled asthma, double-blind, parallel-group, randomised, controlled phase trials, Inhaler, Beclometasone dipropionate, medicine.disease, Glycopyrrolate, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7b98f65dc9b82b58731da63d4b14ab5Test
http://hdl.handle.net/11392/2409883Test

المؤلفون: Jill A. Ohar, Thomas Goodin, Shahin Sanjar, Robert Tosiello

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Male, Time Factors, Health Status, Gastroenterology, Severity of Illness Index, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Forced Expiratory Volume, Medicine, 030212 general & internal medicine, Lung, Original Research, Randomized Controlled Trials as Topic, Aged, 80 and over, COPD, biology, Incidence (epidemiology), LAMA, Age Factors, General Medicine, Lama, Middle Aged, Bronchodilator Agents, Treatment Outcome, disease severity, Female, Adult, medicine.medical_specialty, nebulizer, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, Placebo, Drug Administration Schedule, 03 medical and health sciences, Internal medicine, Severity of illness, Administration, Inhalation, long-acting muscarinic antagonist, Humans, Adverse effect, Glycopyrrolate, Aged, business.industry, Nebulizers and Vaporizers, Recovery of Function, medicine.disease, biology.organism_classification, Clinical trial, 030228 respiratory system, age, Clinical Trials, Phase III as Topic, nebulized glycopyrrolate, business

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdaa1b2bea751017c972c297212c19f8Test
https://www.dovepress.com/efficacy-and-safety-of-a-novel-nebulized-glycopyrrolate-for-the-treatm-peer-reviewed-article-COPDTest

المؤلفون: Dave Singh, Paul Dorinsky, Martin Jenkins, Fernando J. Martinez, Klaus F. Rabe, Magnus Aurivillius, Roopa Trivedi, Patrick Darken

المصدر: Therapeutic Advances in Respiratory Disease
Therapeutic Advances in Respiratory Disease, Vol 15 (2021)

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Budesonide, medicine.medical_specialty, chronic obstructive pulmonary disease, Pulmonary function testing, Diseases of the respiratory system, Pulmonary Disease, Chronic Obstructive, Double-Blind Method, inhaled corticosteroid/long-acting muscarinic antagonist/long-acting β2-agonist (ICS/LAMA/LABA), Formoterol Fumarate, Internal medicine, medicine, Budesonide, Formoterol Fumarate Drug Combination, Humans, Pharmacology (medical), In patient, Metered Dose Inhalers, Lung, Glycopyrrolate, Original Research, COPD, RC705-779, business.industry, pulmonary function, Middle Aged, medicine.disease, Metered-dose inhaler, respiratory tract diseases, Treatment Outcome, triple therapy, BGF metered dose inhaler, Formoterol, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9e27c0f5f8d1cbb0ada7042a2d5b0f8Test
https://doi.org/10.1177/17534666211034329Test